Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract.

[1]  M. Tokita,et al.  Proton beam therapy for large hepatocellular carcinoma. , 2010, International journal of radiation oncology, biology, physics.

[2]  H. Sakurai,et al.  Proton beam therapy for hepatocellular carcinoma , 2009, Cancer.

[3]  N. Fukumitsu,et al.  A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. , 2009, International journal of radiation oncology, biology, physics.

[4]  K. Ohara,et al.  Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis. , 2007, International journal of radiation oncology, biology, physics.

[5]  K. Kagei,et al.  Proton Beam Therapy for Hepatocellular Carcinoma: A Retrospective Review of 162 Patients , 2005, Clinical Cancer Research.

[6]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[7]  J. Furuse,et al.  A phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Bruix,et al.  Prognostic prediction and treatment strategy in hepatocellular carcinoma , 2002, Hepatology.

[9]  C. Suh,et al.  Dose-response relationship in local radiotherapy for hepatocellular carcinoma. , 2001, International journal of radiation oncology, biology, physics.

[10]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[11]  M. Makuuchi,et al.  Results of surgical and nonsurgical treatment for small‐sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan , 2000, Hepatology.

[12]  H. El‐Serag,et al.  Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.

[13]  Kenji Ikeda,et al.  Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the cox proportional hazard model , 1991, Cancer.

[14]  K. Tokunaga,et al.  Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. , 1991, Cancer research.

[15]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[16]  A. Jemal,et al.  Global Cancer Statistics , 2011 .